Clinical Study | Office of Clinical Research

Autosomal Dominant Polycystic Kidney Disease (Adpkd) Testing An Investigational Drug

Posted Date: May 15, 2019

Investigator: Shashi Kant
Type of Study: Drug

This study will evaluate the safety and effectiveness of an investigational medication called tolvaptan in patients with late stage 2 to early stage 4 chronic kidney disease caused by autosomal dominant polycystic kidney disease (ADPKD). The kidney function of participants will be checked through

Criteria:

You May Be Able To Join The Study If You Are: ? Between The Ages Of 18 To 55 Years Old; Patients Ag

Keywords:

Polycystic, Tolvaptan, Kidney, Autosomal

For More Information:

Angela Gordon
513-281-0091 ex
angela.gordon@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List